These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3581517)

  • 1. Effect of cyclophosphamide and its analogs on collagen arthritis in rats.
    Arita C; Kaibara N; Hotokebuchi T; Takagishi K; Arai K
    Clin Immunol Immunopathol; 1987 Jun; 43(3):354-61. PubMed ID: 3581517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of antigen-induced resistance to collagen arthritis by cyclophosphamide.
    Arai K; Kaibara N; Takagishi K; Hotokebuchi T; Arita C
    Clin Immunol Immunopathol; 1987 Jun; 43(3):325-32. PubMed ID: 3581515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-arthritic and immunoregulatory effects of TI-31 on collagen-induced arthritis.
    Komoriya K; Nagata I; Kunisawa K; Takeshita T; Naruchi T
    Jpn J Pharmacol; 1987 Nov; 45(3):389-96. PubMed ID: 3437603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice.
    Cannon GW; McCall S; Cole BC; Griffiths MM; Radov LA; Ward JR
    Agents Actions; 1990 Mar; 29(3-4):315-23. PubMed ID: 2339671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with cyclophosphamide reverses acquired resistance to collagen arthritis subsequent to recovery from passive arthritis.
    Kaibara N; Arai K; Arita C; Hotokebuchi T; Takagishi K
    Cell Immunol; 1986 Sep; 101(2):643-50. PubMed ID: 2944615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of recombinant human granulocyte colony-stimulating factor on passive collagen-induced arthritis transferred with anti-type II collagen antibody.
    Miyahara H; Hotokebuchi T; Saikawa I; Arita C; Takagishi K; Sugioka Y
    Clin Immunol Immunopathol; 1993 Oct; 69(1):69-76. PubMed ID: 7691455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gold sodium thiomalate, cyclosporin A, cyclophosphamide, and placebo on collagen-induced arthritis in rats.
    Cannon GW; McCall S; Cole BC; Radov LA; Ward JR; Griffiths MM
    Agents Actions; 1993 Mar; 38(3-4):240-6. PubMed ID: 8213350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical effects of cyclosporin A on collagen arthritis in rats.
    Kaibara N; Hotokebuchi T; Takagishi K; Katsuki I
    J Exp Med; 1983 Dec; 158(6):2007-15. PubMed ID: 6644238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats.
    Stuart JM; Myers LK; Townes AS; Kang AH
    Arthritis Rheum; 1981 Jun; 24(6):790-4. PubMed ID: 7247975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-induced and adjuvant-induced arthritis in rats. Post-immunization treatment with collagen to suppress or abrogate the arthritic response.
    Phadke K; Fouts R; Parrish JE
    Arthritis Rheum; 1984 Jul; 27(7):797-806. PubMed ID: 6430302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic difference between collagen arthritis and adjuvant arthritis.
    Kaibara N; Hotokebuchi T; Takagishi K; Katsuki I; Morinaga M; Arita C; Jingushi S
    J Exp Med; 1984 May; 159(5):1388-96. PubMed ID: 6201583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease.
    Mackenzie AR; Pick CR; Sibley PR; White BP
    Clin Exp Immunol; 1978 Apr; 32(1):86-96. PubMed ID: 307465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by FK506 of established lesions of collagen-induced arthritis in rats.
    Arita C; Hotokebuchi T; Miyahara H; Arai K; Sugioka Y; Kaibara N
    Clin Exp Immunol; 1990 Dec; 82(3):456-61. PubMed ID: 1702374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antiarthritic compounds on type II collagen-induced arthritis in rats.
    Probert AW; Schrier DJ; Gilbertsen RB
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):167-76. PubMed ID: 6466005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant polyarthritis. VII. The role of type II collagen in pathogenesis.
    Iizuka Y; Chang YH
    Arthritis Rheum; 1982 Nov; 25(11):1325-32. PubMed ID: 7138603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats.
    kerlund K; Erlandsson Harris H; Tracey KJ; Wang H; Fehniger T; Klareskog L; Andersson J; Andersson U
    Clin Exp Immunol; 1999 Jan; 115(1):32-41. PubMed ID: 9933418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of collagen arthritis in rats by heterologous anti-idiotypic antisera against anticollagen antibodies.
    Arita C; Kaibara N; Jingushi S; Takagishi K; Hotokebuchi T; Arai K
    Clin Immunol Immunopathol; 1987 Jun; 43(3):374-81. PubMed ID: 3495379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.
    Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of drugs for activity in established type II collagen arthritis.
    Jones SA; Kennedy AJ; Roberts NA
    Agents Actions; 1982 Dec; 12(5-6):650-6. PubMed ID: 7164936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.